Recent Price Movement and Market Context
On 18 Dec 2025, Chemfab Alkalis' share price touched an intraday low of Rs.439.75, closing the day with a decline of 2.11%. This movement represents a continuation of a three-day losing streak, during which the stock has recorded a cumulative return of -4.89%. The stock's performance today also lagged behind the Commodity Chemicals sector by 1.14%, underscoring its relative weakness within the industry.
Further technical indicators reveal that Chemfab Alkalis is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a persistent bearish trend over multiple time horizons.
In contrast, the broader market index, Sensex, opened flat but moved into negative territory, trading at 84,392.45 points, down 0.2% from the previous close. Notably, Sensex remains approximately 2.09% below its 52-week high of 86,159.02 and is positioned above its 50-day and 200-day moving averages, indicating a more stable market environment compared to Chemfab Alkalis’ stock trajectory.
Long-Term Performance and Valuation Metrics
Over the past year, Chemfab Alkalis has experienced a substantial decline in market value, with its stock price falling by 59.40%. This contrasts sharply with the Sensex’s 5.25% gain over the same period, highlighting the stock’s underperformance relative to the broader market.
The company’s 52-week high was recorded at Rs.1,100.65, illustrating the extent of the price contraction to the current low. This significant drop reflects challenges in sustaining growth and profitability within the Commodity Chemicals sector.
Financially, the company’s operating profit has shown a negative compound annual growth rate of 6.47% over the last five years. The latest quarterly results revealed a 16.36% decline in net sales, accompanied by a net loss after tax (PAT) of Rs.2.01 crore, representing a 274.8% reduction compared to the previous four-quarter average.
Operating profit to interest coverage ratio for the quarter stands at 2.81 times, indicating a tighter margin of safety for debt servicing. Cash and cash equivalents at the half-year mark were reported at Rs.0.89 crore, reflecting limited liquidity buffers.
The company’s return on capital employed (ROCE) is at 1.8%, while the enterprise value to capital employed ratio is 1.6, suggesting a valuation that may be considered elevated relative to the company’s capital efficiency. This premium valuation is notable given the subdued profit trends and the stock’s recent price performance.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Position for Explosive Growth →
Shareholding and Market Interest
Despite its market capitalisation, Chemfab Alkalis has a relatively low presence among domestic mutual funds, which hold only 0.25% of the company’s shares. Given that domestic mutual funds typically conduct detailed research on companies, this limited stake may reflect a cautious stance towards the stock’s current valuation or business outlook.
Debt levels remain modest, with an average debt-to-equity ratio of 0.10 times, indicating limited leverage on the company’s balance sheet. This low gearing provides some financial flexibility, although it has not translated into improved stock performance in recent periods.
Comparative Performance and Sector Positioning
Chemfab Alkalis has underperformed not only the Sensex but also the BSE500 index over the last three years, one year, and three months. This consistent underperformance highlights challenges in maintaining competitive positioning within the Commodity Chemicals sector.
The stock’s premium valuation relative to peers, despite declining profits and returns, suggests a divergence between market pricing and fundamental performance metrics. This gap may be a factor in the stock’s recent price weakness and its fall to the 52-week low.
Considering Chemfab Alkalis ? Wait! SwitchER has found potentially better options in Commodity Chemicals and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Commodity Chemicals + beyond scope
- - Top-rated alternatives ready
Summary of Key Financial Indicators
To summarise, Chemfab Alkalis’ recent financial disclosures and market data reveal a company facing headwinds in sales and profitability. The net sales contraction of 16.36% and a significant PAT decline of 274.8% in the latest quarter underscore the pressures on earnings. Operating profit growth has been negative over the past five years, and cash reserves remain limited.
Valuation metrics such as ROCE and enterprise value to capital employed indicate a relatively high valuation compared to the company’s capital efficiency and profit generation. The stock’s trading below all major moving averages further reflects the subdued market sentiment.
While the company maintains a low debt profile, its share price has not reflected any positive momentum, instead reaching a new 52-week low of Rs.439.75. This price level marks a significant point in the stock’s recent history, reflecting ongoing challenges within the Commodity Chemicals sector and the company’s specific financial performance.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Claim Your Free Year →
